Disease characterization using a partial correlation-based sample-specific network

A single-sample network (SSN) is a biological molecular network constructed from single-sample data given a reference dataset and can provide insights into the mechanisms of individual diseases and aid in the development of personalized medicine. In this study, we proposed a computational method, a partial correlation-based single-sample network (P-SSN), which not only infers a network from each single-sample data given a reference dataset but also retains the direct interactions by excluding indirect interactions (https://github.com/hyhRise/P-SSN). By applying P-SSN to analyze tumor data from the Cancer Genome Atlas and single cell data, we validated the effectiveness of P-SSN in predicting driver mutation genes (DMGs), producing network distance, identifying subtypes and further classifying single cells. In particular, P-SSN is highly effective in predicting DMGs based on single-sample data. P-SSN is also efficient for subtyping complex diseases and for clustering single cells by introducing network distance between any two samples.

[1]  F. Biase,et al.  Cell fate inclination within 2-cell and 4-cell mouse embryos revealed by single-cell RNA sequencing , 2014, Genome research.

[2]  A. Barabasi,et al.  Network medicine--from obesity to the "diseasome". , 2007, The New England journal of medicine.

[3]  C. Sander,et al.  Automated Network Analysis Identifies Core Pathways in Glioblastoma , 2010, PloS one.

[4]  Matthew D. Wilkerson,et al.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..

[5]  Kazuyuki Aihara,et al.  Hunt for the tipping point during endocrine resistance process in breast cancer by dynamic network biomarkers , 2018, Journal of molecular cell biology.

[6]  Yi Zheng,et al.  eGPS 1.0: comprehensive software for multi-omic and evolutionary analyses , 2019, National science review.

[7]  Gary D Bader,et al.  Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers , 2013 .

[8]  N. Neff,et al.  Reconstructing lineage hierarchies of the distal lung epithelium using single cell RNA-seq , 2014, Nature.

[9]  Kyoung-Sik Cho,et al.  Differentiation of subtypes of renal cell carcinoma on helical CT scans. , 2002, AJR. American journal of roentgenology.

[10]  Alex A. Pollen,et al.  Low-coverage single-cell mRNA sequencing reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex , 2014, Nature Biotechnology.

[11]  R. Sandberg,et al.  Single-Cell RNA-Seq Reveals Dynamic, Random Monoallelic Gene Expression in Mammalian Cells , 2014, Science.

[12]  Frédéric Baribaud,et al.  Integrating personalized gene expression profiles into predictive disease-associated gene pools , 2017, npj Systems Biology and Applications.

[13]  Benjamin J. Raphael,et al.  De novo discovery of mutated driver pathways in cancer , 2011 .

[14]  Hans Clevers,et al.  Single-cell messenger RNA sequencing reveals rare intestinal cell types , 2015, Nature.

[15]  Jiming Jiang,et al.  The 'dark matter' in the plant genomes: non-coding and unannotated DNA sequences associated with open chromatin. , 2015, Current opinion in plant biology.

[16]  A. Gonzalez-Perez,et al.  Functional impact bias reveals cancer drivers , 2012, Nucleic acids research.

[17]  Chen Xu,et al.  Identification of cell types from single-cell transcriptomes using a novel clustering method , 2015, Bioinform..

[18]  Kazuyuki Aihara,et al.  Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers , 2012, Scientific Reports.

[19]  Wanwei Zhang,et al.  EdgeMarker: Identifying differentially correlated molecule pairs as edge-biomarkers. , 2014, Journal of theoretical biology.

[20]  D T Severson,et al.  BEARscc determines robustness of single-cell clusters using simulated technical replicates , 2017, Nature Communications.

[21]  Adam Godzik,et al.  e-Driver: a novel method to identify protein regions driving cancer , 2014, Bioinform..

[22]  Christopher Yau,et al.  pcaReduce: hierarchical clustering of single cell transcriptional profiles , 2015, BMC Bioinformatics.

[23]  David G. Kirsch,et al.  Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma , 2016, Genome Biology.

[24]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[25]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[26]  Qingxia Chen,et al.  MSEA: detection and quantification of mutation hotspots through mutation set enrichment analysis , 2014, Genome Biology.

[27]  Hui Wang,et al.  SINCERA: A Pipeline for Single-Cell RNA-Seq Profiling Analysis , 2015, PLoS Comput. Biol..

[28]  Chengyu Liu,et al.  Identification of sample-specific regulations using integrative network level analysis , 2015, BMC Cancer.

[29]  Rui Liu,et al.  Single-sample landscape entropy reveals the imminent phase transition during disease progression. , 2019, Bioinformatics.

[30]  M. Stratton,et al.  The cancer genome , 2009, Nature.

[31]  J. Marioni,et al.  Heterogeneity in Oct4 and Sox2 Targets Biases Cell Fate in 4-Cell Mouse Embryos , 2016, Cell.

[32]  Shi-Hua Zhang,et al.  Discovery of co-occurring driver pathways in cancer , 2014, BMC Bioinformatics.

[33]  Ruiqiang Li,et al.  Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells , 2013, Nature Structural &Molecular Biology.

[34]  David Tamborero,et al.  OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes , 2013, Bioinform..

[35]  K. Aihara,et al.  Personalized characterization of diseases using sample-specific networks , 2016, bioRxiv.

[36]  Kazuyuki Aihara,et al.  Detection for disease tipping points by landscape dynamic network biomarkers , 2018, National science review.

[37]  Ben S. Wittner,et al.  Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells , 2014, Cell reports.

[38]  John Quackenbush,et al.  Estimating Sample-Specific Regulatory Networks , 2015, iScience.

[39]  Uwe Siebert,et al.  Personalized medicine in Europe: not yet personal enough? , 2017, BMC Health Services Research.

[40]  Evan Z. Macosko,et al.  Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets , 2015, Cell.

[41]  L. Hood,et al.  A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. , 2012, New biotechnology.

[42]  L. Hubert,et al.  Comparing partitions , 1985 .